Диссертация (1140935), страница 31
Текст из файла (страница 31)
Hori, Y. Shimizu, S. Fukumoto //Endocrinology. – 2011. – Vol. 152, № 1. – P. 4–10.167.Horl, W.H. Verapamil reverses abnormal [Ca2+]i and carbohydratemetabolism of PMNL of dialysis patients. / W.H. Horl, M. Haag-Weber, B. Mai,S.G. Massry // Kidney International. – 1995. – Vol. 47 (6). – P. 1741–1745.168.Hory, B.G. Absence of response to human parathyroid hormone inathymic mice grafted with human parathyroid adenoma, hyperplasia orparathyroid cells maintained in culture. / B.G. Hory, M.C. Roussanne, S.Rostand, A.
Bourdeau, T.B. Drueke, J. Gogusev // J. Endocrinol. Invest. – 2000.– Vol. 23 (5). – P. 273–279.191169.Hu, M.C. Secreted klotho and chronic kidney disease. / M.C. Hu, O.M.Kuro, O.W. Moe // Adv. Exp. Med. Biol. – 2012. – Vol. 728. – P. 126–157.170.Huber, B.C. Impact of parathyroid hormone on bone marrow-derived stemcell mobilization and migration. / B.C. Huber, U. Grabmaier, S.
Brunner //World. J. Stem. Cells. – 2014. – Vol. 6 (5). – P. 637-643.171.Jaya, A.G. Crowther The Association of 25 Hydroxyvitamin D andParathyroid Hormone with Metabolic Syndrome in Two Ethnic Groups in SouthAfrica / A.G. Jaya, S.A. Norris, H.E. van Deventer, J. Nigel // PLoS One. – 2013.- Vol. 8 (4). - e61282.
- doi: 10.1371/journal.pone.0061282172.Jiang, B. Expression of parathyroid hormone/parathyroid hormone-relatedprotein receptor in vascular endothelial cells. / B. Jiang, S. Morimoto, J. Yang, T.Niinoabu, K. Fukuo, T. Ogihara // J. Cardiovasc. Pharmacol. - 1998. – Vol. 31. –P. S142-144.173.John, G.B. Role of Klotho in aging, phosphate metabolism, and CKD. /G.B. John, C.Y.
Cheng, M. Kuro-o // Am. J. Kidney. Dis. – 2011. – Vol. 58, № 1.– P. 127–134.174.Jung, Y. Regulation of SDF-1 (CXCL12) production by osteoblasts; apossible mechanism for stem cell homing. / Y.Jung, J. Wang, A. Schneider [etal.] // Bone. – 2006. – Vol. 38. – P. 497–508.175.Jüppner, H. A G protein-linked receptor for parathyroid hormone andparathyroid hormone-related peptide. / H. Jüppner, Abou-Samra AB, Freeman M[et al.] // Science. - 1991.
– Vol. 254. – P. 1024–1026.176.Kalinowski, L. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. / L. Kalinowski, L.W. Dobrucki, T. Malinski // J.Endocrinol. – 2001. – Vol. 170. – P. 433–440.177.Kamanna, V.S. Iron sucrose promotes endothelial injury and dysfunctionand monocyte adhesion/infiltration / V.S. Kamanna, S.H.
Ganji, S. Shelkovnikov[et al.] // Am. J. Nephrol. – 2012. – Vol. 35, № 2. – P. 114-119.178.Kaneko, T. T-cell activation modified by parathyroid hormone (PTH) inpatients with end-stage renal disease. / T. Kaneko, E. Osono, N. Hayama, Y.192Lino, A. Terashi // Clinical Nephrology. – 1997. – Vol. 48 (6). – P. 353–358.179.Kaye, M. Long-term outcome following total parathyroidectomy inpatients with end-stage renal disease.
/ M. Kaye, L. Rosenthall, R.O. Hill, R.J.Tabah // Clin. Nephrol. – 1993. – Vol. 39. – P. 192-197.180.Khan, F. Reversible defect of neutrophil chemotaxis and random migrationin primary hyperparathyroidism. / F. Khan, A.J. Khan, C. Papagaroufalis, J.Warman, P. Khan, H.E. Evans. // Journal of Clinical Endocrinology andMetabolism.
– 1979. – Vol. 48 (4). – P. 582–584.181.Keegan, R.F. Oxidative stress and neutrophil function in cats with chronicrenal failure. / R.F. Keegan, C.B. Webb // J. Vet. Intern. Med. - 2010. – Vol. 24.– P. 514–519.182.Kiersztejn, M. Decreased O2 consumption by PMNL from humans and ratswith CRF: role of secondary hyperparathyroidism. / M. Kiersztejn, M.Smogorzewski, P. Thanakitcharu, G.Z. Fadda, S.G. Massry // KidneyInternational. – 1992. – Vol.
42 (3). – P. 602–609.183.Kim, K.W. B cell-associated immune profiles in patients with end-stagerenal disease (ESRD). / K.W. Kim, B.H. Chung, E.J. Jeon, B.M. Kim [et al.] //Exp. Mol. Med. – 2012. – Vol. 44 (8). – P. 465-472.184.Klinger, M. Effect of parathyroid hormone on human T cell activation. / M.Klinger, J.M. Alexiewicz, M. Linker-Israeli [et al.] // Kidney International.
–1990. – Vol. 37 (6). – P. 1543–1551.185.Kohler, H. Active hepatitis B vaccination of dialysis patients and medicalstaff. / H. Kohler, W. Arnold, G. Renschin, H.H. Dormeyer, K.H. Meyer zumBüschenfelde // Kidney International. – 1984. – Vol. 25 (1). – P. 124–128.186.Koizumi, M. Parathyroid function in chronic kidney disease: role ofFGF23-Klotho axis. / M.
Koizumi, H. Komaba, M. Fukagawa // Contrib.Nephrol. – 2013. – Vol. 180. – P. 110-123.187.Kotzmann, H. Effects of parathyroid hormone and serum calcium on thephenotype and function of mononuclear cells in patients with primaryhyperparathyroidism. / H. Kotzmann, M. Köller, C. Abela, M. Clodi, M.193Riedl, W.
Graninger, B. Niederle, A. Luger. // Eur. J. Clin. Invest. – 1998. - Vol.28 (5). – P. 353-358.188.Kramann, R. Parathyroid hormone-related protein and regulation of cellsurvival in the kidney. / R. Kramann, R.K. Schneider // Kidney Int. – 2013. – Vol.83 (5). – P. 777-779.189.Krishnamurthy, G. Low response to HBsAg vaccine in chronic renal failurepatients is not due to intrinsic defect of B cells. / G.
Krishnamurthy, V. Kher, S.Naik. // Scand. J. Urol. Nephrol. – 2002. – Vol. 36 (5). – P. 377-382.190.Kritchevsky, S.B. Hydroxyvitamin D, parathyroid hormone, and mortalityin black and white older adults: the health ABC study / S.B. Kritchevsky, J.A.Tooze, R.H. Neiberg [et al.] // Journal of Clinical Endocrinology & Metabolism.– 2012. – Vol. 97. – P. 4156–4165.191.Kumar, R. The regulation of parathyroid hormone secretion and synthesis. /R. Kumar, J.R. Thompson // J. Am.
Soc. Nephrol. – 2011. – Vol. 22 (2). – P. 216224.192.Langub, M.C. Administration of PTH-(7-84) antagonizes the effects ofPTH-(1-84) on bone in rats with moderate renal failure. / M.C. Langub, M.C.Monier-Faugere, G. Wang, J.P. Williams, N.J. Koszewski, H.H. Malluche. //Endocrinology. – 2003. – Vol. 144. – P. 1135–1138.193.Lanske, B. Parathyroid hormone-related peptide (PTHrP) and parathyroidhormone (PTH)/PTHrP receptor. / B.
Lanske, H.M. Kronenberg // Crit. Rev.Eukaryot. Gene. Expr. – 1998. – Vol. 8. – P. 297–320.194.Lezcano, V. Role of PTHrP in human intestinal Caco-2 cell response tooxidative stress. / V. Lezcano, C. Gentili, A.R. de Boland. // Biochim.
Biophys.Acta. 2013. – Vol. 1833 (12). – P. 2834-2843.195.Li, X. Altered gene expression profile in the kidney of vitamin D receptorknockout mice. / X. Li, W. Zheng, Y.C. Li // J. Cell. Biochem. – 2003. – Vol. 89,№ 4. P. 709–719.196.cells.Li, J.Y. PTH expands short-term murine hemopoietic stem cells through T/J.Y. Li,J.Adams, L.M.Calvi, T.F.Lane, R.DiPaolo, M.N.194Weitzmann, R.
Pacifici // Blood. – 2012. – Vol. 120 (22). – P. 4352-4362.197.Li, Y.C. Renoprotective effects of vitamin D analogs. / Y.C. Li // KidneyInt. – 2009. – Vol. 78. – P. 134–139.198.Liao, M.T. Insulin resistance in patients with chronic kidney disease. /M.T. Liao, C.C. Sung, K.C. Hung, C.C. Wu, L. Lo, K.C.
Lu // J. Biomed.Biotechnol. – 2012. – Vol. 2012. – P. 691369.199.Libetta, C. Dialysis treatment and regulatory T cells. / C. Libetta, P.Esposito, V. Sepe [et al.] // Nephrology Dialysis Transplantation. – 2010. – Vol.25 (5). - P. 1723.200.Libetta, C. Polarization of T-helper lymphocytes toward the Th2 phenotypein uremic patients. / C. Libetta, T. Rampino, A. Dal Canton // Am.
J. Kidney Dis.– 2001. – Vol. 38 (2). – P. 286–295.201.Litjens, N.H. Impaired immune responses and antigen-specific memoryCD4+ T cells in hemodialysis patients. / N.H. Litjens, M. Huisman, M. van denDorpel, M.G. Betjes // J. Am. Soc. Nephrol. – 2008. – Vol. 19 (8). – P. 14831490.202.Litjens, N.H. IL-2 producing memory CD4+ T lymphocytes are closelyassociated with the generation of IgG-secreting plasma cells. / N.H. Litjens, M.Huisman, D. Hijdra, B.M.
Lambrecht, K.J. Stittelaar, M.G. Betjes // J.Immunol. – 2008. – Vol.181. P. 3665–3673.203.London, W.T. An epidemic of hepatitis in a chronic-hemodialysis unit.Australia antigen and differences in host response. / W.T. London, M. Di Figlia,A. Sutnick, B.S. Blumberg // New England Journal of Medicine. – 1969. – Vol.281 (11).
– P. 571–578.204.Lorenzo, J. Osteoimmunology: interactions of the bone and immunesystem. / J. Lorenzo, M. Horowitz, Y. Choi // Endocr. Rev. – 2008. – Vol. 29 (4).– P. 403-40.205.Lowik, C.W.G.M. Parathyroid hormone (PTH) and PTH-like protein(PLP) stimulate interleukin-6 production by osteogenic cells: a possible role ofinterleukin-6 in osteoclastogenesis. / C.W.G.M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
